Pillcheck Webinar – How can our growing knowledge of genetic diversity contribute to better health?

Pillcheck Webinar – How can our growing knowledge of genetic diversity contribute to better health?

Ruslan Dorfman, PhD, MBA6 déc. 2022

How does the Pillcheck pharmacogenetic program make health benefit plans more inclusive, reflecting our true biological diversity? Includes interviews with experts in human genetics and John Papastergiou, a published expert in pharmacogenetics in the pharmacy setting, explaining why doctors might inadvertently ignore our biological diversity. Features results from a Randomized Controlled Trial showing that Pillcheck PGx radically improves outcomes for people who didn’t get the most out of their first prescriptions for depression or anxiety.

Retour au blog

À propos de l'auteur

Ruslan Dorfman

Ruslan Dorfman

PhD, MBA

Founder and CSO Ruslan Dorfman is a trailblazer in personalized medicine, a molecular geneticist, and technology builder. Inspired by direct interactions with Cystic Fibrosis families from all over the world, Dr. Dorfman co-founded GeneYouIn to facilitate access to advanced genetics for the general public. He managed large-scale R&D programs at Sick Kids Hospital, Toronto. He advised Bridgepoint and Mount Sinai hospitals on the implementation of personalized medicine programs. Dr. Dorfman has published thirty peer-reviewed papers on the genetics of Cystic Fibrosis and Pain.